Ipopema Benefit 3 Fizan WSE:IPOBENE3N Stock Report

Last Price

zł127.40

Market Cap

zł0

7D

0%

1Y

n/a

Updated

10 Oct, 2023

Data

Company Financials

Ipopema Benefit 3 Fizan

WSE:IPOBENE3N Stock Report

Mkt Cap: zł0

IPOBENE3N Stock Overview

No business description

IPOBENE3N fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Ipopema Benefit 3 Fizan Competitors

 

 

 

 

 

 

 

 

 

 

 

 

Price History & Performance

Summary of all time highs, changes and price drops for Ipopema Benefit 3 Fizan
Historical stock prices
Current Share Pricezł127.40
52 Week Highzł133.00
52 Week Lowzł114.50
Beta0
1 Month Change0%
3 Month Changen/a
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO6.83%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

IPOBENE3NPL Capital MarketsPL Market
7D0%-1.4%-0.2%
1Yn/a13.5%23.0%

Return vs Industry: Insufficient data to determine how IPOBENE3N performed against the Polish Capital Markets industry.

Return vs Market: Insufficient data to determine how IPOBENE3N performed against the Polish Market.

Price Volatility

Is IPOBENE3N's price volatile compared to industry and market?
IPOBENE3N volatility
IPOBENE3N Average Weekly Movementn/a
Capital Markets Industry Average Movement5.9%
Market Average Movement5.3%
10% most volatile stocks in PL Market10.1%
10% least volatile stocks in PL Market3.5%

Stable Share Price: Insufficient data to determine IPOBENE3N's volatility over the past 3 months.

Volatility Over Time: Insufficient data to determine IPOBENE3N's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/an/an/a

Ipopema Benefit 3 Fizan Fundamentals Summary

How do Ipopema Benefit 3 Fizan's earnings and revenue compare to its market cap?
IPOBENE3N fundamental statistics
Market Capn/a
Earnings (TTM)zł0
Revenue (TTM)n/a

n/a

P/E Ratio

n/a

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
IPOBENE3N income statement (TTM)
Revenuezł0
Cost of Revenuezł0
Gross Profitzł0
Other Expenseszł0
Earningszł0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)0
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did IPOBENE3N perform over the long term?

See historical performance and comparison